Skip to content
NewsBlazeIN – Lifestyle
Author:
One04 Therapeutics
One04 Therapeutics launches on encouraging CPV-104 Phase 1 interim results and plans to expand clinical development to include kidney diseases and dry AMD
September 15, 2026